Proinsulin: A unique autoantigen triggering autoimmune diabetes

Journal of Clinical Investigation

Volumn 116, Issue 12, 2006, Pages 3108-3110

  You, Sylvaine ^a   Chatenoud, Lucienne ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; GLUCOSE 6 PHOSPHATASE; PROINSULIN;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; DIABETES MELLITUS; ENZYME ACTIVE SITE; HUMAN; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMALS; AUTOANTIGENS; DIABETES MELLITUS, TYPE 1; GLUCOSE-6-PHOSPHATASE; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; MICE, SCID; MICE, TRANSGENIC; MODELS, BIOLOGICAL; PROINSULIN; PROTEINS; T-LYMPHOCYTE SUBSETS;

EID: 33845337973     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI30760     Document Type: Review

References (25)

1. Lehmann, P.V., Forsthuber, T., Miller, A., and Sercarz, E.E. 1992. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature. 358:155-157.
2. Yu, M., Johnson, J.M., and Tuohy, V.K. 1996. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183:1777-1788.
3. Tuohy, V.K., Yu, M., Weinstock-Guttman, B., and Kinkel, R.P. 1997. Diversity and plasticity of self recognition during the development of multiple sclerosis. J. Clin. Invest. 99:1682-1690.
4. Tuohy, V.K., et al. 1998. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 164:93-100.
5. Miller, S.D., et al. 1997. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3:1133-1136.
6. Tisch, R., et al. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in nonobese diabetic mice. Nature. 366:72-75.
7. Kaufman, D.L., et al. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature. 366:69-72.
8. Krishnamurthy, B., et al. 2006. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. J. Clin. Invest. 116:3258-3265. doi:10.1172/JCI29602.
9. Wegmann, D.R., Norbury-glaser, M., and Daniel, D. 1994. Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur. J. Immunol. 24:1853-1857.
10. Daniel, D., Gill, R.G., Schloot, N., and Wegmann, D. 1995. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25:1056-1062.
11. Verdaguer, J., et al. 1997. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 186:1663-1676.
12. Lieberman, S.M., et al. 2003. Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc. Natl. Acad. Sci. U. S. A. 100:8384-8388.
13. Utsugi, T., et al. 1996. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8(+) T-cell clones in vivo. Diabetes. 45:1121-1131.
14. French, M.B., et al. 1997. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes. 46:34-39.
15. Nakayama, M., et al. 2005. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature. 435:220-223.
16. McMahon, E.J., Bailey, S.L., Castenada, C.V., Waldner, H., and Miller, S.D. 2005. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 11:335-339.
17. Vanderlugt, C.L., and Miller, S.D. 2002. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat. Rev. Immunol. 2:85-95.
18. Curnow, J., Corlett, L., Willcox, N., and Vincent, A. 2001. Presentation by myoblasts of an epitope from endogenous acetylcholine receptor indicates a potential role in the spreading of the immune response. J. Neuroimmunol. 115:127-134.
19. Dai, Y., et al. 1999. Enhancing or suppressive effects of antibodies on processing of a pathogenic T cell epitope in thyroglobulin. J. Immunol. 162:6987-6992.
20. Serreze, D.V., et al. 1996. B lymphocytes are essential for the initiation of T cell- mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu(null) mice. J. Exp. Med. 184:2049-2053.
21. Serreze, D.V., et al. 1998. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Immunol. 161:3912-3918.
22. Reijonen, H., Daniels, T.L., Lernmark, A., and Nepom, G.T. 2000. GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65. Diabetes. 49:1621-1626.
23. Tian, J., Zekzer, D., Lu, Y., Dang, H., and Kaufman, D.L. 2006. B cells are crucial for determinant spreading of T cell autoimmunity among beta cell antigens in diabetes-prone nonobese diabetic mice. J. Immunol. 176:2654-2661.
24. Al Sabbagh, A., Miller, A., Santos, L.M., and Weiner, H.L. 1994. Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse. Eur. J. Immunol. 24:2104-2109.
25. Tian, J., Lehmann, P.V., and Kaufman, D.L. 1997. Determinant spreading of T helper cell 2 (Th2) responses to pancreatic islet autoantigens. J. Exp. Med. 186:2039-2043.